IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White, +11

Blood

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

DG Maloney, A.J. Grillo-López, David Bodkin, +6

Journal of Clinical Oncology

Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

J. Gutheil, Tanya Campbell, Paul R. Pierce, +4

PubMed

Tumor BiologyEndothelial CellsIntegrin Alphavbeta3MedicineImmunology +13

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

Ronald B. Natale, David Bodkin, Ramaswamy Govindan, +8

Journal of Clinical Oncology

Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer

Charles Butts, David Bodkin, Edward L. Middleman, +13

Journal of Clinical Oncology

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White, +11

Blood

ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial

Ronald B. Natale, David Bodkin, Ramaswamy Govindan, +7

Journal of Clinical Oncology

Receiving GefitinibCancer ManagementPharmacotherapyTumor BiologyPre-clinical Pharmacology +16

Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer

Peter D. Boasberg, Charles H. Redfern, Gregory A. Daniels, +3

Cancer Chemotherapy and Pharmacology

Gastrointestinal OncologyMedicineMelanomaPathologyColorectal Cancer +8

A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer

Thomas J. Lynch, David Fenton, Vera Hirsh, +9

Journal of Thoracic Oncology

Randomized Phase 2MedicinePharmacologyPathologyAnti-cancer Agent +6

Aircraft Stability and Control Characteristics Determined by System Identification of CFD Simulations

John Dean, Scott Morton, David McDaniel, +2

AIAA Atmospheric Flight Mechanics Conference and Exhibit

AeroacousticsAeronauticsEngineeringAerospace EngineeringAerospace Simulation +11